p53 mutations are associated with resistance to chemotherapy and short survival in hematologic malignanciesEric Wattel, Pierre Fenaux, Bruno Quesnel et al.|Blood|1994Cited by 581
Efficacy of bortezomib, cyclophosphamide and dexamethasone in treatment-naive patients with high-risk cardiac AL amyloidosis (Mayo Clinic stage III)Arnaud Jaccard, Chris Venner, Raymond L. Comenzo et al.|Haematologica|2014Cited by 129